Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
A methodology to assess the population size and estimate the needed resources for new licensed medications by combining clinical and administrative databases: The example of glycated haemoglobin in type 2 diabetes
Francesco Lapi, Elisa Bianchini, Ettore Marconi, Gerardo Medea, Carlo Piccinni, Aldo Maggioni, Letizia Dondi, Antonella Pedrini, Nello Martini, Claudio Cricelli (2023). A methodology to assess the population size and estimate the needed resources for new licensed medications by combining clinical and administrative databases: The example of glycated haemoglobin in type 2 diabetes. , 32(10), DOI: https://doi.org/10.1002/pds.5641.
Article5 days agoTo support the use of NT-proBNP to better detect heart failure in patients with type 2 diabetes
Francesco Lapi, Ettore Marconi, Gerardo Medea, Damiano Parretti, Carlo Piccinni, Aldo Maggioni, Claudio Cricelli (2023). To support the use of NT-proBNP to better detect heart failure in patients with type 2 diabetes. , 82(1), DOI: https://doi.org/10.1007/s12020-023-03419-2.
Article5 days agoTo retrieve values of albuminuria to define the size of <scp>CKD</scp> patients eligible to <scp>SGLT‐2Is</scp>: An explorative analysis using a primary care database
Francesco Lapi, Ettore Marconi, Gaetano Piccinocchi, Gerardo Medea, Carlo Piccinni, Aldo Maggioni, Claudio Cricelli (2023). To retrieve values of albuminuria to define the size of <scp>CKD</scp> patients eligible to <scp>SGLT‐2Is</scp>: An explorative analysis using a primary care database. , 33(1), DOI: https://doi.org/10.1002/pds.5742.
Article5 days agoHow many and who are patients with heart failure eligible to SGLT2 inhibitors? Responses from the combination of administrative healthcare and primary care databases
Carlo Piccinni, Letizia Dondi, Silvia Calabria, Giulia Ronconi, Antonella Pedrini, Francesco Lapi, Ettore Marconi, Damiano Parretti, Gerardo Medea, Claudio Cricelli, Nello Martini, Aldo Maggioni (2022). How many and who are patients with heart failure eligible to SGLT2 inhibitors? Responses from the combination of administrative healthcare and primary care databases. , 371, DOI: https://doi.org/10.1016/j.ijcard.2022.09.053.
Article5 days agoReal World Evidence (RWE) to Enhance Value-Based Market Access of the PCSK9 Inihibitors in Italy: Treatment Patterns and Cv-Related Hospitalizations Among High Risk Hefh and Secondary Prevention Patients in Three Real-World Data Systems
E Pessina, Luca Degli Esposti, Francesco Lapi, Aldo Maggioni, C Uslenghi (2016). Real World Evidence (RWE) to Enhance Value-Based Market Access of the PCSK9 Inihibitors in Italy: Treatment Patterns and Cv-Related Hospitalizations Among High Risk Hefh and Secondary Prevention Patients in Three Real-World Data Systems. , 19(7), DOI: https://doi.org/10.1016/j.jval.2016.09.1821.
Article9 hours ago